The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Survival after nonmyeloablative versus myeloablative allotransplantation for AML/MDS.
M. R. Khawaja
No relevant relationships to disclose
J. E. Schwartz
No relevant relationships to disclose
M. Yu
No relevant relationships to disclose
M. J. Robertson
No relevant relationships to disclose
G. H. Vance
No relevant relationships to disclose
S. Srivastava
No relevant relationships to disclose
L. L. Wood
No relevant relationships to disclose
R. Abonour
No relevant relationships to disclose
K. Cornetta
No relevant relationships to disclose
S. Farag
No relevant relationships to disclose
L. D. Cripe
No relevant relationships to disclose
R. P. Nelson
No relevant relationships to disclose